• Optomed swung to a third-quarter 2026 net profit of EUR 479,000 from a year-earlier loss.
• Revenue rose 18% year over year to EUR 5.19 million, driven primarily by strong Devices segment performance.
• Operating cash flow turned positive year over year at EUR 1.01 million.
• The unchanged outlook calls for full-year 2026 revenue growth compared with 2025, with larger customer orders affecting quarterly timing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Optomed plc published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.